STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
ARWR ARROWHEAD PHARMACEUTICALS INCORPORATED StockScouter® Report
4
StockScouter® Score
ARROWHEAD PHARMACEUTICALS INCORPORATED, a mid cap growth company in the healthcare sector, is expected to perform in line with the market over the next six months with average risk
10 is the best possible rating. Learn more.
Summary
Positives
- One or more analysts has significantly increased quarterly earnings estimates for ARWR. Positive
- Moving average analysis for ARWR suggests flat price movement over the medium term. Neutral
Concerns
- The most recent quarterly earnings report was significantly lower than analysts’ consensus forecast. Negative
- The enterprise value-to-sales ratio is much higher than the average for comparably-sized companies in the StockScouter universe. Very Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that mid cap stocks will be neutral, growth stocks will be neutral, and healthcare stocks will be neutral.
Expected Risk/Return
Core Model Grades
C
C
F
D